Interleukin-4 inhibits granulocyte-macrophage colony-stimulating factor, interleukin-6, and tumor necrosis factor-alpha expression by human monocytes in response to polymethylmethacrylate particle challenge in vitro

Michael C.D. Trindade, Yasuharu Nakashima, Martin Lind, Doo Hoon Sun, Stuart B. Goodman, William J. Maloney, David J. Schurman, R. Lane Smith

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The outcome of total joint arthroplasty is determined by biological events at the bone-implant interface. Macrophages phagocytose implant or wear debris at the interface and release proinflammatory mediators such as interleukins 1 and 6, tumor necrosis factor-alpha, and prostaglandin E2. These mediators are thought to contribute to the resorption of periprosthetic bone. Previous studies of tissues harvested from the bone-implant interface of failed orthopaedic implants demonstrated a possible role for two other cytokines, granulocyte-macrophage colony-stimulating factor and interleukin- 4. The present study examined the effects of in vitro challenge with polymethylmethacrylate particles on the expression of granulocyte-macrophage colony-stimulating factor by primary human monocytes/macrophages and the role of interleukin-4 in regulating this expression. The polymethylmethacrylate particles caused a dose-dependent release of granulocytemacrophage colony- stimulating factor at 48 hours. This release was accompanied by increased expression of interleukins 6 and 1 beta and tumor necrosis factor-alpha. Release of the lysosomal enzyme hexosaminidase also increased in response to the particles. Interleukin-4 inhibited the expression of granulocyte- macrophage colony-stimulating factor, interleukin-6, and tumor necrosis factor-alpha at 48 hours in a dose-dependent manner. The data presented in this study confirm the hypothesis that interleukin-4 downregulates particleinduced activation of macrophages, as demonstrated by the decreased release of proinflammatory mediators.

Original languageEnglish
Pages (from-to)797-802
Number of pages6
JournalJournal of Orthopaedic Research
Volume17
Issue number6
DOIs
Publication statusPublished - Jan 1 1999
Externally publishedYes

Fingerprint

Polymethyl Methacrylate
Granulocyte-Macrophage Colony-Stimulating Factor
Interleukin-4
Monocytes
Interleukin-6
Tumor Necrosis Factor-alpha
Macrophages
Hexosaminidases
Colony-Stimulating Factors
Macrophage Activation
Bone Resorption
Interleukin-1beta
Interleukin-1
Phagocytosis
Dinoprostone
Arthroplasty
Orthopedics
Down-Regulation
Joints
Cytokines

All Science Journal Classification (ASJC) codes

  • Orthopedics and Sports Medicine

Cite this

Interleukin-4 inhibits granulocyte-macrophage colony-stimulating factor, interleukin-6, and tumor necrosis factor-alpha expression by human monocytes in response to polymethylmethacrylate particle challenge in vitro. / Trindade, Michael C.D.; Nakashima, Yasuharu; Lind, Martin; Sun, Doo Hoon; Goodman, Stuart B.; Maloney, William J.; Schurman, David J.; Smith, R. Lane.

In: Journal of Orthopaedic Research, Vol. 17, No. 6, 01.01.1999, p. 797-802.

Research output: Contribution to journalArticle

Trindade, Michael C.D. ; Nakashima, Yasuharu ; Lind, Martin ; Sun, Doo Hoon ; Goodman, Stuart B. ; Maloney, William J. ; Schurman, David J. ; Smith, R. Lane. / Interleukin-4 inhibits granulocyte-macrophage colony-stimulating factor, interleukin-6, and tumor necrosis factor-alpha expression by human monocytes in response to polymethylmethacrylate particle challenge in vitro. In: Journal of Orthopaedic Research. 1999 ; Vol. 17, No. 6. pp. 797-802.
@article{f58460b35c274540b56a122365e114ce,
title = "Interleukin-4 inhibits granulocyte-macrophage colony-stimulating factor, interleukin-6, and tumor necrosis factor-alpha expression by human monocytes in response to polymethylmethacrylate particle challenge in vitro",
abstract = "The outcome of total joint arthroplasty is determined by biological events at the bone-implant interface. Macrophages phagocytose implant or wear debris at the interface and release proinflammatory mediators such as interleukins 1 and 6, tumor necrosis factor-alpha, and prostaglandin E2. These mediators are thought to contribute to the resorption of periprosthetic bone. Previous studies of tissues harvested from the bone-implant interface of failed orthopaedic implants demonstrated a possible role for two other cytokines, granulocyte-macrophage colony-stimulating factor and interleukin- 4. The present study examined the effects of in vitro challenge with polymethylmethacrylate particles on the expression of granulocyte-macrophage colony-stimulating factor by primary human monocytes/macrophages and the role of interleukin-4 in regulating this expression. The polymethylmethacrylate particles caused a dose-dependent release of granulocytemacrophage colony- stimulating factor at 48 hours. This release was accompanied by increased expression of interleukins 6 and 1 beta and tumor necrosis factor-alpha. Release of the lysosomal enzyme hexosaminidase also increased in response to the particles. Interleukin-4 inhibited the expression of granulocyte- macrophage colony-stimulating factor, interleukin-6, and tumor necrosis factor-alpha at 48 hours in a dose-dependent manner. The data presented in this study confirm the hypothesis that interleukin-4 downregulates particleinduced activation of macrophages, as demonstrated by the decreased release of proinflammatory mediators.",
author = "Trindade, {Michael C.D.} and Yasuharu Nakashima and Martin Lind and Sun, {Doo Hoon} and Goodman, {Stuart B.} and Maloney, {William J.} and Schurman, {David J.} and Smith, {R. Lane}",
year = "1999",
month = "1",
day = "1",
doi = "10.1002/jor.1100170602",
language = "English",
volume = "17",
pages = "797--802",
journal = "Journal of Orthopaedic Research",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Interleukin-4 inhibits granulocyte-macrophage colony-stimulating factor, interleukin-6, and tumor necrosis factor-alpha expression by human monocytes in response to polymethylmethacrylate particle challenge in vitro

AU - Trindade, Michael C.D.

AU - Nakashima, Yasuharu

AU - Lind, Martin

AU - Sun, Doo Hoon

AU - Goodman, Stuart B.

AU - Maloney, William J.

AU - Schurman, David J.

AU - Smith, R. Lane

PY - 1999/1/1

Y1 - 1999/1/1

N2 - The outcome of total joint arthroplasty is determined by biological events at the bone-implant interface. Macrophages phagocytose implant or wear debris at the interface and release proinflammatory mediators such as interleukins 1 and 6, tumor necrosis factor-alpha, and prostaglandin E2. These mediators are thought to contribute to the resorption of periprosthetic bone. Previous studies of tissues harvested from the bone-implant interface of failed orthopaedic implants demonstrated a possible role for two other cytokines, granulocyte-macrophage colony-stimulating factor and interleukin- 4. The present study examined the effects of in vitro challenge with polymethylmethacrylate particles on the expression of granulocyte-macrophage colony-stimulating factor by primary human monocytes/macrophages and the role of interleukin-4 in regulating this expression. The polymethylmethacrylate particles caused a dose-dependent release of granulocytemacrophage colony- stimulating factor at 48 hours. This release was accompanied by increased expression of interleukins 6 and 1 beta and tumor necrosis factor-alpha. Release of the lysosomal enzyme hexosaminidase also increased in response to the particles. Interleukin-4 inhibited the expression of granulocyte- macrophage colony-stimulating factor, interleukin-6, and tumor necrosis factor-alpha at 48 hours in a dose-dependent manner. The data presented in this study confirm the hypothesis that interleukin-4 downregulates particleinduced activation of macrophages, as demonstrated by the decreased release of proinflammatory mediators.

AB - The outcome of total joint arthroplasty is determined by biological events at the bone-implant interface. Macrophages phagocytose implant or wear debris at the interface and release proinflammatory mediators such as interleukins 1 and 6, tumor necrosis factor-alpha, and prostaglandin E2. These mediators are thought to contribute to the resorption of periprosthetic bone. Previous studies of tissues harvested from the bone-implant interface of failed orthopaedic implants demonstrated a possible role for two other cytokines, granulocyte-macrophage colony-stimulating factor and interleukin- 4. The present study examined the effects of in vitro challenge with polymethylmethacrylate particles on the expression of granulocyte-macrophage colony-stimulating factor by primary human monocytes/macrophages and the role of interleukin-4 in regulating this expression. The polymethylmethacrylate particles caused a dose-dependent release of granulocytemacrophage colony- stimulating factor at 48 hours. This release was accompanied by increased expression of interleukins 6 and 1 beta and tumor necrosis factor-alpha. Release of the lysosomal enzyme hexosaminidase also increased in response to the particles. Interleukin-4 inhibited the expression of granulocyte- macrophage colony-stimulating factor, interleukin-6, and tumor necrosis factor-alpha at 48 hours in a dose-dependent manner. The data presented in this study confirm the hypothesis that interleukin-4 downregulates particleinduced activation of macrophages, as demonstrated by the decreased release of proinflammatory mediators.

UR - http://www.scopus.com/inward/record.url?scp=0033400503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033400503&partnerID=8YFLogxK

U2 - 10.1002/jor.1100170602

DO - 10.1002/jor.1100170602

M3 - Article

C2 - 10632444

AN - SCOPUS:0033400503

VL - 17

SP - 797

EP - 802

JO - Journal of Orthopaedic Research

JF - Journal of Orthopaedic Research

SN - 0736-0266

IS - 6

ER -